7301 - 7350 of 8571 Results
Title
Year
- Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data2020RESTRICTEDTitle: Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient DataJournal Name: BioMed Research InternationalPublisher: Hindawi LimitedVol: 2020Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/7390473Best OA location URL: https://downloads.hindawi.com/journals/bmri/2020/7390473.pdfCitation Count: 3
-
RESTRICTEDTitle: Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2Journal Name: Annals of NeurologyPublisher: WileyVol: 71Issue #: 3Start Page: 370End Page: 384Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.22687Best OA location URL: https://europepmc.org/articles/pmc3354734?pdf=renderCitation Count: 270
-
RESTRICTEDTitle: Regeneration through Reprogramming Adult Cell Identity in VivoJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 185Issue #: 10Start Page: 2619End Page: 2628Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ajpath.2015.02.025Best OA location URL: http://ajp.amjpathol.org/article/S0002944015002588/pdfCitation Count: 15
-
RESTRICTEDTitle: Obtaining Objective Clinical Measures During Telehealth Evaluations of DysarthriaJournal Name: American Journal of Speech-Language PathologyPublisher: American Speech Language Hearing AssociationVol: 30Issue #: 2Start Page: 503End Page: 516Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1044/2020_ajslp-20-00243Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740561Citation Count: 16
- Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses’ Health Study2016RESTRICTEDTitle: Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses’ Health StudyJournal Name: American Journal of Public HealthPublisher: American Public Health AssociationVol: 106Issue #: 9Start Page: 1650End Page: 1655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2105/ajph.2016.303324Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981803Citation Count: 21
-
RESTRICTEDTitle: The Neuropsychiatry of Parkinson Disease: A Perfect StormJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 27Issue #: 9Start Page: 998End Page: 1018Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2019.03.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015280Citation Count: 92
- Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies2019RESTRICTEDTitle: Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association StudiesJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 176Issue #: 3Start Page: 217End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2018.18070857Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2018.18070857Citation Count: 252
-
RESTRICTEDTitle: Artificial Intelligence in Neuroradiology: Current Status and Future Directions.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3174/ajnr.a6681Citation Count: 14
-
OPENTitle: Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozinJournal Name: NeoplasiaPublisher: Elsevier BVVol: 23Issue #: 4Start Page: 391End Page: 399Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neo.2021.02.003Best OA location URL: https://doi.org/10.1016/j.neo.2021.02.003Citation Count: 16
- Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson’s disease2022RESTRICTEDTitle: Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 169Issue #:Start Page: 105721End Page: 105721Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105721Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105721Citation Count: 6
-
RESTRICTED
- Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 42022RESTRICTEDTitle: Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4Journal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 1Start Page: 307End Page: 317Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12797Best OA location URL: https://escholarship.org/content/qt7br8n7s3/qt7br8n7s3.pdf?t=rxcrmfCitation Count: 35
-
RESTRICTEDTitle: DYT‐TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 5Start Page: 659End Page: 675Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13452Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13452Citation Count: 7
- Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease2022RESTRICTEDTitle: Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 869End Page: 878Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13523Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13523Citation Count: 33
- Childhood‐Onset Choreo‐Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature Review2022RESTRICTEDTitle: Childhood‐Onset Choreo‐Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 101End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13529Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13529Citation Count: 2
- Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and Recommendations2022RESTRICTEDTitle: Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and RecommendationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 175End Page: 189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13586Best OA location URL: https://discovery.ucl.ac.uk/10157300/1/Rating%20scales%20for%20medication%20adherence%20in%20Parkinson%20s%20disease.pdfCitation Count: 1
-
RESTRICTEDTitle: Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosisJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 701End Page: 712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.94Best OA location URL: https://europepmc.org/articles/pmc3049925?pdf=renderCitation Count: 119
- Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches2018RESTRICTEDTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://europepmc.org/articles/pmc7234797?pdf=renderCitation Count: 24
-
RESTRICTEDTitle: Activation of the E3 ubiquitin ligase ParkinJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 43Issue #: 2Start Page: 269End Page: 274Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bst20140321Best OA location URL: https://europepmc.org/articles/pmc4859148?pdf=renderCitation Count: 45
-
RESTRICTEDTitle: LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's diseaseJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 40Issue #: 5Start Page: 1074End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bst20120093Best OA location URL: https://europepmc.org/articles/pmc3701022?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: The LRRK2–macroautophagy axis and its relevance to Parkinson's diseaseJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 45Issue #: 1Start Page: 155End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bst20160265Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/45/1/155/432837/bst-2016-0265.pdfCitation Count: 61
-
RESTRICTEDTitle: Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2Journal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 40Issue #: 5Start Page: 1042End Page: 1046Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bst20120112Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112632Citation Count: 18
-
RESTRICTEDTitle: Ubiquitin and Parkinson's disease through the looking glass of geneticsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1439End Page: 1451Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160498Best OA location URL: https://portlandpress.com/biochemj/article-pdf/474/9/1439/689414/bcj-2016-0498c.pdfCitation Count: 54
-
RESTRICTEDTitle: Current Challenges Towards the Development of a Blood Test for Parkinson’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 4Issue #: 4Start Page: 153End Page: 164Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics4040153Best OA location URL: https://www.mdpi.com/2075-4418/4/4/153/pdf?version=1413988424Citation Count: 9
- Vesicular degradation pathways in neurons: at the crossroads of autophagy and endo-lysosomal degradation2019RESTRICTEDTitle: Vesicular degradation pathways in neurons: at the crossroads of autophagy and endo-lysosomal degradationJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.conb.2019.01.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629518Citation Count: 21
-
RESTRICTEDTitle: The Therapeutic Potential of Metformin in Neurodegenerative DiseasesJournal Name: Frontiers in EndocrinologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fendo.2018.00400Best OA location URL: https://www.frontiersin.org/articles/10.3389/fendo.2018.00400/pdfCitation Count: 209
- Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies2016RESTRICTEDTitle: Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and TechnologiesJournal Name: Frontiers in Integrative NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnint.2016.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnint.2016.00038/pdfCitation Count: 50
-
RESTRICTEDTitle: T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's DiseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00239Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00239/pdfCitation Count: 97
-
RESTRICTEDTitle: Role of Peripheral Immune Cells for Development and Recovery of Chronic PainJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2021.641588Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2021.641588/pdfCitation Count: 29
-
RESTRICTEDTitle: Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T CellsJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00303Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00303/pdfCitation Count: 121
-
RESTRICTEDTitle: Structural biology of the LRRK2 GTPase and kinase domains: implications for regulationJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00032Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00032/pdfCitation Count: 71
- Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders2014RESTRICTEDTitle: Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disordersJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00048Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00048/pdfCitation Count: 69
-
RESTRICTEDTitle: Crosstalk between Lysosomes and Mitochondria in Parkinson's DiseaseJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2017.00110Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2017.00110/pdfCitation Count: 77
-
RESTRICTEDTitle: Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein ProteoformsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.598446Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.598446/pdfCitation Count: 18
-
RESTRICTEDTitle: Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and OpportunitiesJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.615461Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.615461/pdfCitation Count: 86
- In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons2020RESTRICTEDTitle: In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and ConsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.559791Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.559791/pdfCitation Count: 15
-
RESTRICTEDTitle: Neurodegeneration: Keeping ATF4 on a Tight LeashJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2017.00410Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2017.00410/pdfCitation Count: 56
-
RESTRICTEDTitle: Spectrum of impulse control behaviours in Parkinson’s disease: pathophysiology and managementJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 7Start Page: 703End Page: 711Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-322453Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/7/703.full.pdfCitation Count: 33
-
RESTRICTEDTitle: The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: s1Start Page: S65End Page: S73Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202104Best OA location URL: https://europepmc.org/articles/pmc7592668?pdf=renderCitation Count: 38
- Simple system – substantial share: The use of Dictyostelium in cell biology and molecular medicine2013RESTRICTEDTitle: Simple system – substantial share: The use of Dictyostelium in cell biology and molecular medicineJournal Name: European Journal of Cell BiologyPublisher: Elsevier BVVol: 92Issue #: 2Start Page: 45End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejcb.2012.10.003Best OA location URL: https://pure.rug.nl/ws/files/141909462/1_s2.0_S0171933512001616_main.pdfCitation Count: 84
-
RESTRICTEDTitle: Neurodegenerative Disease Risk in Carriers of Autosomal Recessive DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.679927Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.679927/pdfCitation Count: 7
- Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case Series2020RESTRICTEDTitle: Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case SeriesJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 43Issue #: 3Start Page: 61End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000384Citation Count: 7
- Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical Applications2021RESTRICTEDTitle: Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical ApplicationsJournal Name: BiologyPublisher: MDPI AGVol: 10Issue #: 5Start Page: 359End Page: 359Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biology10050359Best OA location URL: https://www.mdpi.com/2079-7737/10/5/359/pdf?version=1619157483Citation Count: 84
-
RESTRICTEDTitle: Domotics, Smart Homes, and Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s1Start Page: S55End Page: S63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202398Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202398?id=journal-of-parkinsons-disease%2Fjpd202398Citation Count: 8
-
RESTRICTEDTitle: Current Concepts in the Treatment of Multiple System AtrophyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 6End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12145Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12145Citation Count: 24
- Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease2013RESTRICTEDTitle: Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 34Issue #: 1Start Page: 35End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2012.07.018Citation Count: 68
- Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity2019RESTRICTEDTitle: Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese NeurotoxicityJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 4Start Page: 994End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20040994Best OA location URL: https://www.mdpi.com/1422-0067/20/4/994/pdf?version=1551081390Citation Count: 19
-
RESTRICTEDTitle: Mitochondria, lysosomes, and dysfunction: their meaning in neurodegenerationJournal Name: Journal of NeurochemistryPublisher: WileyVol: 147Issue #: 3Start Page: 291End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.14471Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14471Citation Count: 88
- Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential2017RESTRICTEDTitle: Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potentialJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 97Issue #:Start Page: 90End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.07.009Citation Count: 149
- Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studies2017RESTRICTEDTitle: Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studiesJournal Name: Annals of NeurologyPublisher: WileyVol: 81Issue #: 2Start Page: 171End Page: 180Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24859Best OA location URL: https://kclpure.kcl.ac.uk/portal/files/62952075/Serontin_Transporter_in_Parkinson_s_disease_SERT_Accepted_GREEN_AAM.pdfCitation Count: 79